Skip to main content

Lyell Immunopharma Inc

For the period ended Mar 31, 2024. Filed May 6, 2024.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2024 · Filed May 6, 2024

LYEL$15.42+3.8%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Item 6. Exhibits

ExhibitNumberDescriptionFormFile NumberExhibit/AppendixReferenceFilingDateFiledHerewith
3.1Amended and Restated Certificate of Incorporation.S-8333-2572494.106/21/2021
3.2Amended and Restated Bylaws.10-Q001-405023.211/07/2023
4.1Form of Common Stock Certificate.S-1/A333-2564704.106/09/2021
4.2Amended and Restated Investors' Rights Agreement, by and among the Registrant and certain of its stockholders, dated March 5, 2020.S-1333-2564704.205/25/2021
31.1*Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a).X
31.2*Certification of Principal Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a).X
32.1*«Certifications of Principal Executive Officer and Principal Financial Officer Pursuant to 18 U.S.C. Section 1350.X
101.INSXBRL Instance Document.The XBRL instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.
101.SCHInline XBRL Taxonomy Extension Schema DocumentX
101.CALInline XBRL Taxonomy Extension Calculation Linkbase DocumentX
101.DEFInline XBRL Taxonomy Extension Definition Linkbase DocumentX
101.LABInline XBRL Taxonomy Extension Label Linkbase DocumentX
101.PREInline XBRL Taxonomy Extension Presentation Linkbase DocumentX
104Cover Page Interactive Data File (embedded within the Inline XBRL document)X

*Filed herewith.

« The certification attached as Exhibit 32.1 that accompanies this Quarterly Report on Form 10-Q is not deemed filed with the Securities and Exchange Commission and is not to be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, whether made before or after the date of this Quarterly Report on Form 10-Q, irrespective of any general incorporation language contained in such filing.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.